Robert Wood Johnson Center for MS

New Brunswick, New Jersey

Academic MS Center
6 Active TrialsLarge Center
11 MS centers statewide · Ranked #3 in New Jersey for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedPart of Major Health System

You’re looking at a large academic MS center where your care is shaped by a team of MS-trained specialists and university ties. You’ll likely appreciate the breadth of testing, pediatric MS services, and access to neuro-ophthalmology and other specialty evaluations. Because this is a single-location center, you may need to plan ahead and work through phone scheduling for visits.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services3/5
Clinical Trials & Research4/5
Insurance & Navigation Help1/5
Scheduling & Virtual Care2/5

About Robert Wood Johnson Center for MS

This center stands out for offering both adult and pediatric MS services within a Rutgers academic medical setting. It also combines specialty care with a broad diagnostic workup and formal training through a fellowship program.

Robert Wood Johnson Center for MS cares for people with adult and pediatric multiple sclerosis, as well as related conditions like transverse myelitis, ADEM, and optic neuritis. The team includes MS-trained neurologists, advanced practice nurses, and neuro-ophthalmology support, with 26 participating providers involved in care. Patients also have access to diagnostic tools such as MRI, spinal fluid analysis, evoked potentials, and neuro-ophthalmologic, urologic, and neuropsychological evaluation. The center is part of Rutgers and Robert Wood Johnson University Hospital.

Robert Wood Johnson Center for MS is an academic MS center in New Brunswick that brings together neurologists, advanced practice nurses, and neuro-ophthalmology expertise. Patients can be seen for multiple sclerosis, pediatric MS, transverse myelitis, ADEM, optic neuritis, and other neuroimmunology concerns. The center is closely connected with Rutgers Robert Wood Johnson Medical School, Rutgers University, and Robert Wood Johnson University Hospital. You can also expect access to advanced testing and a fellowship program that supports specialty training.

Featured Care Team Members

Suhayl S. Dhib-Jalbut, MD
Department Chair; Chair in Multiple Sclerosis
Multiple sclerosis, neuroimmunology
Vikram V. Bhise, MD
Epilepsy, adult and pediatric multiple sclerosis, transverse myelitis, acute disseminated encephalomyelitis (ADEM), optic neuritis
Frederick E. Lepore, MD
Neuro-ophthalmology

Specialized Programs

Pediatric MS services
Multiple Sclerosis Center

Partnerships & Referral Network

  • Robert Wood Johnson University Hospital (consultative and inpatient services)

Services & Treatments

What They Treat
Multiple sclerosisAdult multiple sclerosisPediatric multiple sclerosisTransverse myelitisAcute disseminated encephalomyelitis (ADEM)Optic neuritisNeuroimmunology
How They Treat It
Accurate diagnosisComprehensive treatment plansInnovative researchClinical evaluation by MS-trained neurologistsPediatric MS servicesMagnetic resonance imaging (MRI)Spinal fluid analysisEvoked potentialsNeuro-ophthalmologic evaluationUrologic studiesNeuropsychological evaluation
Diagnostics
Magnetic resonance imaging (MRI)Spinal fluid analysisEvoked potentialsNeuro-ophthalmologic evaluationUrologic (bladder dysfunction) studiesNeuropsychological evaluation

Research & Clinical Trials

This center is currently involved in 6 clinical trials — ranked #3 in New Jersey for active trials

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumab PlaceboFingolimodFingolimod Placebo
ABA-101 in Participants With Progressive Multiple Sclerosis
Abata Therapeutics
ACTIVE NOT RECRUITINGPHASE1
ABA-101
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.
RECRUITINGPHASE1, PHASE2
AAV9-hSyn1-miGRIK2
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
Interferon beta-1aFingolimodPlacebo capsulePlacebo i.m. injection

Insurance & Access

Contact
Clinical Academic Bldg 6th Flr, 125 Paterson Street Ste 6200, New Brunswick, NJ 08901
Insurance & Support

FAQs from Robert Wood Johnson Center for MS

You can schedule by phone at 732-235-7733.

Yes. The center offers pediatric MS services and treats both adult and pediatric multiple sclerosis.

The center offers MRI, spinal fluid analysis, evoked potentials, neuro-ophthalmologic evaluation, urologic studies, and neuropsychological evaluation.

In addition to MS, the team treats transverse myelitis, acute disseminated encephalomyelitis (ADEM), optic neuritis, and other neuroimmunology concerns.

Yes. The center includes a fellowship program that supports specialty training.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website